Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Rare-disease families can now invest in Mahzi Therapeutics' gene therapy, giving patients a financial stake in developing ...

A recovering IPO market, surging mergers and acquisitions fuel more biotech venture deals.

UBS Michael Yee joins 'Closing Bell Overtime' to talk what could be ahead for M&A in the biotech space.

The antibody uses a dual mechanism of action and works to block the interaction between TSLP and its receptor.

China’s nascent challenge has U.S. biotech startups hustling to emulate China’s efficiency and speed in drug development.

The two startups are the third and fourth, respectively, to outline offerings this month and aim to capitalize on momentum ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Though funding totals represented the highest first-half sum since the start of 2022, industry watchers are concerned that ...

CNBC’s Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter. Instead, he highlighted a group ...

Another wave of layoffs has hit one of the Bay Area's biggest biotech companies—and the latest cuts push a troubling trend ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.